Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The 1st Annual Alkermes Pathways Research Awards (SM) Program granted approximately $400,000 for research projects focused on substance use disorders
January 16, 2019
By: Betsy Louda
Alkermes plc has announced the recipients of the ALKERMES PATHWAYS RESEARCH AWARDS program, designed to support the next generation of researchers working on the front lines to advance understanding and awareness of central nervous system (CNS) disorders.
In its inaugural year, the Pathways program will provide an aggregate of $400,000 in grants to junior investigators who have demonstrated their commitment to helping those living with substance use disorders (SUD), including those associated with the use of opioids and alcohol.
“An estimated one-in-seven people in the U.S. will develop a substance use disorder in their lifetime, which is why we urgently need to accelerate research efforts focused on improving prevention, treatment and awareness of this public health crisis,” said Craig Hopkinson, M.D., chief medical officer and senior vice president of Medicines Development and Medical Affairs at Alkermes. “By supporting promising researchers in this field, we aim to propel innovative ideas forward, and ultimately make a positive impact on those living with central nervous system disorders.”
The annual Pathways program provides funding for up to four research projects with grant amounts of up to $100,000 per project. The four inaugural recipients were recognized at an awards ceremony on Jan. 14, 2019 for their outstanding work and creative ideas to advance research and help support those living with CNS disorders.
The recipients of the inaugural Pathways program grants include:
“Brain diseases are complicated, and we often don’t fully understand the cause or how treatments work,” said grant recipient Sarah L. Withey, Ph.D., Harvard Medical School, McLean Hospital. “Given the devastating and widespread effects of the opioid epidemic, I am more inspired than ever to help discover sustainable and scalable solutions that may make a meaningful difference for not only the millions of people who are battling addiction, but also their families, friends and entire communities.”
To qualify, junior investigators must be M.D.s, Ph.D.s, or equivalent, within five years of initial academic appointment or current post-doctoral fellows, and affiliated with a medical or research institution within the U.S. Applicants are evaluated by an independent review committee comprised of specialists in psychiatry, neurobiology, pharmacology and behavioral science from academic research centers focused on SUDs.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !